Namba H - Search Results

1

Childhood thyroid carcinoma with BRAFT1799A mutation shows unique pathological features of poor differentiation.

Kumagai A, Namba H, Mitsutake N, Saenko VA, Ohtsuru A, Ito M, Noh JY, Sugino K, Ito K, Yamashita S. Kumagai A, et al. Among authors: namba h. Oncol Rep. 2006 Jul;16(1):123-6. Oncol Rep. 2006. PMID: 16786134

2

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers.

Namba H, Nakashima M, Hayashi T, Hayashida N, Maeda S, Rogounovitch TI, Ohtsuru A, Saenko VA, Kanematsu T, Yamashita S. Namba H, et al. J Clin Endocrinol Metab. 2003 Sep;88(9):4393-7. doi: 10.1210/jc.2003-030305. J Clin Endocrinol Metab. 2003. PMID: 12970315

3

Low frequency of BRAFT1796A mutations in childhood thyroid carcinomas.

Kumagai A, Namba H, Saenko VA, Ashizawa K, Ohtsuru A, Ito M, Ishikawa N, Sugino K, Ito K, Jeremiah S, Thomas GA, Bogdanova TI, Tronko MD, Nagayasu T, Shibata Y, Yamashita S. Kumagai A, et al. Among authors: namba h. J Clin Endocrinol Metab. 2004 Sep;89(9):4280-4. doi: 10.1210/jc.2004-0172. J Clin Endocrinol Metab. 2004. PMID: 15356022

4

The BRAFT1796A transversion is a prevalent mutational event in human thyroid microcarcinoma.

Sedliarou I, Saenko V, Lantsov D, Rogounovitch T, Namba H, Abrosimov A, Lushnikov E, Kumagai A, Nakashima M, Meirmanov S, Mine M, Hayashi T, Yamashita S. Sedliarou I, et al. Among authors: namba h. Int J Oncol. 2004 Dec;25(6):1729-35. Int J Oncol. 2004. PMID: 15547711

5

A rapid and simple detection method for the BRAF(T1796A) mutation in fine-needle aspirated thyroid carcinoma cells.

Hayashida N, Namba H, Kumagai A, Hayashi T, Ohtsuru A, Ito M, Saenko VA, Maeda S, Kanematsu T, Yamashita S. Hayashida N, et al. Among authors: namba h. Thyroid. 2004 Nov;14(11):910-5. doi: 10.1089/thy.2004.14.910. Thyroid. 2004. PMID: 15671769

6

Vitamin D3 treatment for locally advanced thyroid cancer: a case report.

Morishita M, Ohtsuru A, Kumagai A, Namba H, Sato N, Hayashi T, Yamashita S. Morishita M, et al. Among authors: namba h. Endocr J. 2005 Oct;52(5):613-6. doi: 10.1507/endocrj.52.613. Endocr J. 2005. PMID: 16284441 Free article.

7

TP53 codon 72 polymorphism in radiation-associated human papillary thyroid cancer.

Rogounovitch TI, Saenko VA, Ashizawa K, Sedliarou IA, Namba H, Abrosimov AY, Lushnikov EF, Roumiantsev PO, Konova MV, Petoukhova NS, Tchebotareva IV, Ivanov VK, Chekin SY, Bogdanova TI, Tronko MD, Tsyb AF, Thomas GA, Yamashita S. Rogounovitch TI, et al. Among authors: namba h. Oncol Rep. 2006 Apr;15(4):949-56. Oncol Rep. 2006. PMID: 16525684

8

No evidence of ARAF, CRAF and MET mutations in BRAFT1799A negative human papillary thyroid carcinoma.

Kumagai A, Namba H, Takakura S, Inamasu E, Saenko VA, Ohtsuru A, Yamashita S. Kumagai A, et al. Among authors: namba h. Endocr J. 2006 Oct;53(5):615-20. doi: 10.1507/endocrj.k06-058. Epub 2006 Aug 8. Endocr J. 2006. PMID: 16896265 Free article.

9

BRAFV600E promotes invasiveness of thyroid cancer cells through nuclear factor kappaB activation.

Palona I, Namba H, Mitsutake N, Starenki D, Podtcheko A, Sedliarou I, Ohtsuru A, Saenko V, Nagayama Y, Umezawa K, Yamashita S. Palona I, et al. Among authors: namba h. Endocrinology. 2006 Dec;147(12):5699-707. doi: 10.1210/en.2006-0400. Epub 2006 Sep 7. Endocrinology. 2006. PMID: 16959844

10

Different structural components of conventional papillary thyroid carcinoma display mostly identical BRAF status.

Abrosimov A, Saenko V, Rogounovitch T, Namba H, Lushnikov E, Mitsutake N, Yamashita S. Abrosimov A, et al. Among authors: namba h. Int J Cancer. 2007 Jan 1;120(1):196-200. doi: 10.1002/ijc.22290. Int J Cancer. 2007. PMID: 17044028

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

543 results

Search Page

Filters